Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA fragmentation factor subunit alpha (DFFA) is a regulatory protein encoded by the DFFA gene. It is a key component of the DNA fragmentation factor (DFF) complex, which functions as a heterodimer of a 45-kDa regulatory subunit (DFFA) and a 40-kDa subunit with endonuclease activity (DFFB). DFFA acts as an inhibitor of the caspase-activated DNase (DFFB/CAD) until it is cleaved by caspase-3 during apoptosis. Upon cleavage, DFFA releases DFFB, which then digests chromosomal DNA into nucleosomal fragments, a hallmark of apoptosis. DFFA is therefore central to the execution phase of apoptosis, linking caspase activation to DNA fragmentation and chromatin condensation[1][2][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA fragmentation factor subunit alpha (DFFA).